ArticleFrontiers in oncology2024
The deep learning radiomics nomogram helps to evaluate the lymph node status in cervical adenocarcinoma/adenosquamous carcinoma.
Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The accurate assessment of lymph node metastasis (LNM) can facilitate clinical decision-making on radiotherapy or radical hysterectomy (RH) in cervical adenocarcinoma (AC)/adenosquamous carcinoma (ASC). This study aims to develop a deep learning radiomics nomogram (DLRN) to preoperatively evaluate LNM in cervical AC/ASC. Materials and methods: A total of 652 patients from a multicenter were enrolled and randomly allocated into primary, internal, and external validation cohorts. The radiomics features were extracted from axial T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and contrast-enhanced T1-weighted imaging (CE-T1WI). The DL features from T2WI, DWI, and CE-T1WI were exported from Resnet 34, which was pretrained by 14 million natural images of the ImageNet dataset. The radscore (RS) and DL score (DLS) were independently obtained after repeatability test, Pearson correlation coefficient (PCC), minimum redundancy maximum relevance (MRMR), and least absolute shrinkage and selection operator (LASSO) algorithm performed on the radiomics and DL feature sets. The DLRN was then developed by integrating the RS, DLS, and independent clinicopathological factors for evaluating the LNM in cervical AC/ASC. Results: The nomogram of DLRN-integrated FIGO stage, menopause, RS, and DLS achieved AUCs of 0.79 (95% CI, 0.74-0.83), 0.87 (95% CI, 0.81-0.92), and 0.86 (95% CI, 0.79-0.91) in the primary, internal, and external validation cohorts. Compared with the RS, DLS, and clinical models, DLRN had a significant higher AUC for evaluating LNM (all P < 0.005). Conclusions: The nomogram of DLRN can accurately evaluate LNM in cervical AC/ASC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.